The 1.9 Å structure of α-N-acetylgalactosaminidase: Molecular basis of glycosidase deficiency diseases

Structure

Volumn 10, Issue 3, 2002, Pages 425-434

  Garman, Scott C ^a   Hannick, Linda ^a   Zhu, Alex ^b   Garboczi, David N ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NEW YORK BLOOD CENTER   (United States)

Author keywords

N acetylgalactosamine; E.C. 3.2.1.49; Fabry disease; Glycoside hydrolase family 27; Retaining glycosidase; Schindler disease

Indexed keywords

ALPHA GALACTOSIDASE; ALPHA N ACETYLGALACTOSAMINIDASE; AMINO ACID; LIGAND; BETA N ACETYLHEXOSAMINIDASE; N ACETYLGALACTOSAMINE; NAGA PROTEIN, HUMAN;

AMINO ACID SEQUENCE; ARTICLE; BLOOD GROUP A; BLOOD GROUP B; BLOOD GROUP O; CATALYSIS; CRYSTAL STRUCTURE; ENZYME ACTIVE SITE; FABRY DISEASE; GENE MUTATION; HUMAN; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ANALYSIS; X RAY CRYSTALLOGRAPHY; ANIMAL; BINDING SITE; CHEMICAL STRUCTURE; CHEMISTRY; CHICKEN; DIMERIZATION; ENZYMOLOGY; GENETICS; LYSOSOME; LYSOSOME STORAGE DISEASE; METABOLISM; MOLECULAR GENETICS; MUTATION; PROTEIN SECONDARY STRUCTURE; PROTEIN TERTIARY STRUCTURE; SEQUENCE ALIGNMENT;

ACETYLGALACTOSAMINE; ALPHA-N-ACETYLGALACTOSAMINIDASE; AMINO ACID SEQUENCE; ANIMALS; BINDING SITES; CATALYSIS; CHICKENS; CRYSTALLOGRAPHY, X-RAY; DIMERIZATION; HEXOSAMINIDASES; HUMANS; LIGANDS; LYSOSOMAL STORAGE DISEASES; LYSOSOMES; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MOLECULAR STRUCTURE; MUTATION; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; SEQUENCE ALIGNMENT;

EID: 0036124422     PISSN: 09692126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-2126(02)00726-8     Document Type: Article

References (70)

1. α-N-acetylgalactosaminidase deficiency: Schindler disease
2. Murine α-N-acetylgalactosaminidase: Isolation and expression of a full-length cDNA and genomic organization; further evidence of an α-galactosidase gene family
3. Lysosomal α-N-acetylgalactosaminidase deficiency: A new inherited metabolic disease
4. α-N-acetylgalactosaminidase deficiency, a new lysosomal storage disorder
5. Neuroaxonal dystrophy due to lysosomal α-N-acetylgalactosaminidase deficiency
6. Novel lysosomal glycoaminoacid storage disease with angiokeratoma corporis diffusum
7. Schindler disease: The molecular lesion in the α-N-acetylgalactosaminidase gene that causes an infantile neuroaxonal dystrophy
8. The molecular lesion in the α-N-acetylgalactosaminidase gene that causes angiokeratoma corporis diffusum with glycopeptiduria
9. Human α-N-acetylgalactosaminidase (α-NAGA) deficiency: New mutations and the paradox between genotype and phenotype
10. A new case of α-N-acetylgalactosaminidase deficiency with angiokeratoma corporis diffusum, with Meniere's syndrome and without mental retardation
11. Ein Beitrag Zur Kenntnis der Purpura haemorrhagica nodularis (Purpura papulosa hemorrhagica Habrae)
12. Enzymatic defect in Fabry's disease. Ceramidetrihexosidase deficiency
13. α-Galactosidase A deficiency: Fabry disease
14. Safety and efficacy of recombinant human α-galactosidase A - Replacement therapy in Fabry's disease
15. Enzyme replacement therapy in Fabry disease: A randomized controlled trial
16. Enzymatic corrections for cells derived from Fabry disease patients by a recombinant adenovirus vector
17. Preselective gene therapy for Fabry disease
18. Group B erythrocytes enzymatically converted to group O survive normally in A, B, and O individuals
19. Further evidence for the presence of A antigen on group B erythrocytes through the use of specific exoglycosidases
20. Multiple-unit and second transfusions of red cells enzymatically converted from group B to group O: Report on the end of phase 1 trials
21. The action on soluble blood group A substances of an α-N-acetylgalactosaminidase from Helix pomatia
22. Characterization of recombinant α-galactosidase for use in seroconversion from blood group B to O of human erythrocytes
23. Structural and sequence-based classification of glycoside hydrolases
24. Glycoside hydrolases and glycosyltransferases: Families and functional modules
25. Crystallization and preliminary X-ray analysis of human α-galactosidase A complex
26. Mechanisms of enzymatic glycoside hydrolysis
27. Glycosidase mechanisms
28. Glycosidase mechanisms: Anatomy of a finely tuned catalyst
29. Crystal structure of Thermoactinomyces vulgaris R-47 α-amylase II (TVAII) hydrolyzing cyclodextrins and pullulan at 2.6 Å resolution
30. Dali: A network tool for protein structure comparison
31. Purification and properties of the two major isozymes of α-galactosidase from human placenta
32. Studies on human liver α-galactosidases. II. Purification and enzymatic properties of α-galactosidase B (α-N-acetylgalactosaminidase)
33. α-N-acetylgalactosaminidase: Isolation, properties and distribution of the human enzyme
34. Human α-N-acetylgalactosaminidase-molecular cloning, nucleotide sequence, and expression of a full-length cDNA. Homology with human α-galactosidase A suggests evolution from a common ancestral gene
35. Structural studies of α-N-acetylgalactosaminidase: Effect of glycosylation on the level of expression, secretion efficiency, and enzyme activity
36. Sequence differences between glycosylated and non-glycosylated Asn-X-Thr/Ser acceptor sites: Implications for protein engineering
37. Structural basis of lectin-carbohydrate recognition
38. Lectin-carbohydrate interactions: Different folds, common recognition principles
39. Mechanism of N-acetylgalactosamine binding to a C-type animal lectin carbohydrate-recognition domain
40. Structures of the Erythrina corallodendron lectin and of its complexes with mono- and disaccharides
41. The identification of α-galactosidase B from human liver as an α-N-acetylgalactosaminidase
42. The identity of α-galactosidase B from human liver
43. Protein folding and association: Insights from the interfacial and thermodynamic properties of hydrocarbons
44. Stereochemistry and the mechanism of enzymatic reactions
45. Structures and mechanisms of glycosyl hydrolases
46. Mutagenesis of glycosidases
47. The synthesis, testing and use of 5-fluoro-α-D-galactosyl fluoride to trap an intermediate on green coffee bean α-galactosidase and identify the catalytic nucleophile
48. Identification of Asp-130 as the catalytic nucleophile in the main α-galactosidase from Phanerochaete chrysosporium, a family 27 glycosyl hydrolase
49. Structures of Thermoactinomyces vulgaris R-47 α-amylase II complexed with substrate analogues
50. Crystallographic complexes of glucoamylase with maltooligosaccharide analogs: Relationship of stereochemical distortions at the nonreducing end to the catalytic mechanism
51. Xylan binding subsite mapping in the xylanase from Penicillium simplicissimum using xylooligosaccharides as cryo-protectant
52. Dissection of protein-carbohydrate interactions in mutant hen egg-white lysozyme complexes and their hydrolytic activity
53. Conserved catalytic machinery and the prediction of a common fold for several families of glycosyl hydrolases
54. Trp-16 is essential for the activity of α-galactosidase and α-N-acetylgalactosaminidase
55. Identification of tyrosine 108 in coffee bean α-galactosidase as an essential residue for the enzyme activity
56. Human α-N-acetylgalactosaminidase (α-NAGA) deficiency: No association with neuroaxonal dystrophy?
57. Galactosialidosis
58. The human gene mutation database
59. Improvement in cardiac function in the cardiac variant of Fabry's disease with galactose-infusion therapy
60. Expression, purification, and characterization of recombinant α-N-acetylgalactosaminidase produced in the yeast Pichia pastoris
61. Processing of X-ray diffraction data collected in oscillation mode
62. The CCP4 suite: Programs for protein crystallography
63. Improved methods for building protein models in electron density maps and the location of errors in these models
64. Crystallography & NMR system: A new software suite for macromolecular structure determination
65. Cross-validated maximum likelihood enhances crystallographic simulated annealing refinement
66. New applications of simulated annealing in X-ray crystallography and solution NMR
67. Improved Fourier coefficients for maps using phases from partial structures with errors
68. Procheck: A program to check the stereochemical quality of protein structures
69. MolScript: A program to produce both detailed and schematic plots of protein structures
70. An extensively modified version of MolScript that includes greatly enhanced coloring capabilities